NMD Pharma

Investment area
Novo Seeds
Region
Europe
Date of investment
June 2016

NMD Pharma is developing novel treatments for Neuromuscular diseases such as Myasthenia gravis and ALS. The company is in preclinical development.

NMD Pharma

Investment area
Novo Seeds
Region
Europe
Date of investment
June 2016

NMD Pharma is developing novel treatments for Neuromuscular diseases such as Myasthenia gravis and ALS. The company is in preclinical development.

NMD Pharma

Investment area
Novo Seeds
Region
Europe
Date of investment
June 2016

NMD Pharma is developing novel treatments for Neuromuscular diseases such as Myasthenia gravis and ALS. The company is in preclinical development.